🇺🇸 FDA
Patent

US 8187605

Means for the inhibition of anti-β1-adrenergic receptor antibodies

granted A61PA61P29/00A61P31/00

Quick answer

US patent 8187605 (Means for the inhibition of anti-β1-adrenergic receptor antibodies) held by Julius-Maximilians-Universitat Wurzburg expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P29/00, A61P31/00, A61P37/06, A61P43/00